# FDA 483 - Noble Pharma, LLC - Unknown Date

Source: https://www.globalkeysolutions.net/records/483/noble-pharma-llc/bc71bd7c-3765-4391-beed-b399aece1c1f

> FDA 483 for Noble Pharma, LLC on Unknown Date. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Noble Pharma, LLC
- Product Type: drugs
- Office Name: Minneapolis District Office
- Summary: An FDA inspection of Noble Pharma LLC in Menomonie, WI, from March 3-6, 2025, revealed significant deficiencies in drug manufacturing processes. Observations included a lack of validation for equipment, processes, and container closure, inadequate facility configuration to prevent contamination, and insufficient computer system controls. These issues indicate a failure to ensure product quality and integrity.

## Related Documents

- [483 - 2025-08-22](https://www.globalkeysolutions.net/records/483/noble-pharma-llc/ecb7beef-f833-48b1-9251-cdd991f47a54)
- [483 - 2025-03-06](https://www.globalkeysolutions.net/records/483/noble-pharma-llc/c04e1180-5007-41e7-b4e4-bfa5b00c9d91)

## Related Officers

- [Lori B. Wikstrom](https://www.globalkeysolutions.net/people/lori-b-wikstrom/19d938f7-4a5d-42b9-b2d1-e92cdb63bb0d)
- [Aerial A. Smith](https://www.globalkeysolutions.net/people/aerial-a-smith/1f2a9d0e-91b0-4e59-ace1-0527785217e1)

Company: https://www.globalkeysolutions.net/companies/noble-pharma-llc/7fd1f37f-ba04-49a3-a115-ad7110e9f8a5

Office: https://www.globalkeysolutions.net/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d